Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1101-1110 of 1,220) with videos related to

Pageof 122
Sort By:
JAMA Network Open|December 13, 2021
Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal CarcinomaShuo-Han Zheng, Song-Ran Liu, Hai-Bo Wang, et al.
Cancer Cell International|March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinomaZheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
Journal of the American Heart Association|May 1, 2020
CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1Xiaolin Wu, Lijin Lin, Juan-Juan Qin, et al.
International Journal of Cancer|April 18, 2014
Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trialFang-Hui Zhao, Feng-Cai Zhu, Wen Chen, et al.
Global Challenges (Hoboken, NJ)|March 31, 2021
A Robust, Safe, and Scalable Magnetic Nanoparticle Workflow for RNA Extraction of Pathogens from Clinical and Wastewater SamplesGerardo Ramos-Mandujano, Rahul Salunke, Sara Mfarrej, et al.
Investigational New Drugs|March 9, 2023
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 studyJames Chih-Hsin Yang, Wu-Chou Su, Chao-Hua Chiu, et al.
Journal of Hematology & Oncology|November 28, 2021
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinomaJia-Cheng Lu, Peng-Fei Zhang, Xiao-Yong Huang, et al.
Theranostics|August 2, 2019
The miR-561-5p/CX<sub>3</sub>CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX<sub>3</sub>CR1<sup>+</sup> Natural Killer Cells InfiltrationEr-Bao Chen, Zheng-Jun Zhou, Kun Xiao, et al.
Journal of Pain and Symptom Management|October 31, 2003
Are nurses prepared to manage cancer pain? A national survey of nurses' knowledge about pain control in TaiwanYeur-Hur Lai, Mei-Ling Chen, Li-Yun Tsai, et al.
Oncotarget|September 9, 2017
Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinomaEr-Bao Chen, Shao-Lai Zhou, Xu-Guang Pang, et al.
Pageof 122

Showing results (1101-1110 of 1,220) with videos related to

Sort By:
Pageof 122
JAMA Network Open|December 13, 2021
Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal CarcinomaShuo-Han Zheng, Song-Ran Liu, Hai-Bo Wang, et al.
Cancer Cell International|March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinomaZheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
Journal of the American Heart Association|May 1, 2020
CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1Xiaolin Wu, Lijin Lin, Juan-Juan Qin, et al.
International Journal of Cancer|April 18, 2014
Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trialFang-Hui Zhao, Feng-Cai Zhu, Wen Chen, et al.
Global Challenges (Hoboken, NJ)|March 31, 2021
A Robust, Safe, and Scalable Magnetic Nanoparticle Workflow for RNA Extraction of Pathogens from Clinical and Wastewater SamplesGerardo Ramos-Mandujano, Rahul Salunke, Sara Mfarrej, et al.
Investigational New Drugs|March 9, 2023
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 studyJames Chih-Hsin Yang, Wu-Chou Su, Chao-Hua Chiu, et al.
Journal of Hematology & Oncology|November 28, 2021
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinomaJia-Cheng Lu, Peng-Fei Zhang, Xiao-Yong Huang, et al.
Theranostics|August 2, 2019
The miR-561-5p/CX<sub>3</sub>CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX<sub>3</sub>CR1<sup>+</sup> Natural Killer Cells InfiltrationEr-Bao Chen, Zheng-Jun Zhou, Kun Xiao, et al.
Journal of Pain and Symptom Management|October 31, 2003
Are nurses prepared to manage cancer pain? A national survey of nurses' knowledge about pain control in TaiwanYeur-Hur Lai, Mei-Ling Chen, Li-Yun Tsai, et al.
Oncotarget|September 9, 2017
Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinomaEr-Bao Chen, Shao-Lai Zhou, Xu-Guang Pang, et al.
Pageof 122